Role of SOCS1 Gene in Chronic Hepatitis C Virus Patients: A Mini-Review

2020 ◽  
Vol 40 (9) ◽  
pp. 454-459
Author(s):  
Braira Wahid
Hepatology ◽  
2000 ◽  
Vol 31 (4) ◽  
pp. 997-1004 ◽  
Author(s):  
Lucia De Franceschi ◽  
Giovanna Fattovich ◽  
Franco Turrini ◽  
Kodjo Ayi ◽  
Carlo Brugnara ◽  
...  

2013 ◽  
Vol 20 (7) ◽  
pp. 470-477 ◽  
Author(s):  
W.-K. Seto ◽  
O. T.-Y. Tsang ◽  
K. Liu ◽  
J. M.-C. Chan ◽  
D. K.-H. Wong ◽  
...  

2011 ◽  
Vol 140 (5) ◽  
pp. S-934
Author(s):  
Fasiha Kanwal ◽  
Tuyen Hoang ◽  
Jennifer R. Kramer ◽  
Timothy Chrusciel ◽  
Steven M. Asch ◽  
...  

2004 ◽  
Vol 78 (4) ◽  
pp. 2152-2157 ◽  
Author(s):  
Christel Gremion ◽  
Benno Grabscheid ◽  
Benno Wölk ◽  
Darius Moradpour ◽  
Jürg Reichen ◽  
...  

ABSTRACT The role of Fas-mediated lysis of hepatocytes in hepatitis C virus (HCV)-induced injury is frequently discussed. We therefore analyzed the effect of the number of HCV antigen-expressing cells, the mode of antigen presentation, and the number of cytotoxic T lymphocytes in a coculture system mimicking cellular components of the liver. Here, we show that endogenously processed HCV proteins are capable of inducing bystander killing. We further demonstrate that 0.8 to 1.5% of cells presenting HCV antigens suffice to induce lysis of 10 to 29% of bystander cells, suggesting that the mechanism may be operative at low fractions of infected versus uninfected hepatocytes in vivo. Our data underscore the role of the Fas pathway in HCV-related liver injury and support the exploration of Fas-based treatment strategies for patients with chronic hepatitis C virus infection.


Sign in / Sign up

Export Citation Format

Share Document